These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17988798)

  • 1. Mucin-type O-glycosylation and its potential use in drug and vaccine development.
    Tarp MA; Clausen H
    Biochim Biophys Acta; 2008 Mar; 1780(3):546-63. PubMed ID: 17988798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
    Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
    Bennett EP; Mandel U; Clausen H; Gerken TA; Fritz TA; Tabak LA
    Glycobiology; 2012 Jun; 22(6):736-56. PubMed ID: 22183981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    Gerken TA; Zhang J; Levine J; Elhammer A
    J Biol Chem; 2002 Dec; 277(51):49850-62. PubMed ID: 12397077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.
    Gerken TA; Tep C; Rarick J
    Biochemistry; 2004 Aug; 43(30):9888-900. PubMed ID: 15274643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
    Perrine CL; Ganguli A; Wu P; Bertozzi CR; Fritz TA; Raman J; Tabak LA; Gerken TA
    J Biol Chem; 2009 Jul; 284(30):20387-97. PubMed ID: 19460755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
    Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
    Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
    Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
    Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I; Dowler T; Paulsen H
    Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
    Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
    Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
    Hassan H; Reis CA; Bennett EP; Mirgorodskaya E; Roepstorff P; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
    J Biol Chem; 2000 Dec; 275(49):38197-205. PubMed ID: 10984485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.
    Stadie TR; Chai W; Lawson AM; Byfield PG; Hanisch FG
    Eur J Biochem; 1995 Apr; 229(1):140-7. PubMed ID: 7744025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides.
    Hanisch FG; Reis CA; Clausen H; Paulsen H
    Glycobiology; 2001 Sep; 11(9):731-40. PubMed ID: 11555617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.
    Pedersen JW; Bennett EP; Schjoldager KT; Meldal M; Holmér AP; Blixt O; Cló E; Levery SB; Clausen H; Wandall HH
    J Biol Chem; 2011 Sep; 286(37):32684-96. PubMed ID: 21768105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopeptide N-acetylgalactosaminyltransferase specificities for O-glycosylated sites on MUC5AC mucin motif peptides.
    Tetaert D; Ten Hagen KG; Richet C; Boersma A; Gagnon J; Degand P
    Biochem J; 2001 Jul; 357(Pt 1):313-20. PubMed ID: 11415465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
    Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
    Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
    Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
    BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.